⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2792653 | 1.00 | — | — | |
| SCHEMBL594482 | 1.00 | — | — | |
| SCHEMBL28262449 | 0.97 | MME (0.41) | — | |
| Hydrazine SCHEMBL27924753 | 0.97 | RAB9A (0.41) | — | |
| SCHEMBL23314577 | 0.80 | ALDH1A1 (0.44) | — | |
| SCHEMBL8526197 | 0.80 | — | — | |
| SCHEMBL14534806 | 0.80 | — | — | |
| SCHEMBL2661638 | 0.80 | — | — | |
| SCHEMBL9500795 | 0.79 | — | — | |
| SCHEMBL20981925 | 0.79 | TGFBR1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250336540-A1 | METABOLITE PREDICTORS FOR LUNG CANCER | JANSSEN PHARMACEUTICA NV (BE) | 2025-10-30 | — | — | US | claimed |
| EP-4515242-A1 | METABOLITE PREDICTORS FOR LUNG CANCER | JANSSEN Pharmaceutica NV (BE) | 2025-03-05 | — | — | EP | claimed |
| CN-117947279-B | Method for improving leaching rate of gold ore | 中国矿业大学(北京) | 2024-07-05 | — | — | CN | claimed |
| CN-117947279-A | Method for improving leaching rate of gold ore | 中国矿业大学(北京) | 2024-04-30 | — | — | CN | claimed |
| WO-2023209218-A1 | METABOLITE PREDICTORS FOR LUNG CANCER | JANSSEN PHARMACEUTICA NV (BE) | 2023-11-02 | — | — | WO | claimed |
| CN-113368245-A | High-osmotic-pressure hyaluronic acid liquid for treating osteoarthritis | 深圳市第二人民医院(深圳市转化医学研究院) | 2021-09-10 | — | — | CN | claimed |
| CN-113234669-A | Culture solution for delaying dedifferentiation of chondrocytes and preparation method thereof | 深圳市第二人民医院(深圳市转化医学研究院) | 2021-08-10 | — | — | CN | claimed |
| US-20100130416-A1 | MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTS | ARCHER PHARMACEUTICALS, INC. (US) | 2010-05-27 | — | — | US | claimed |
| WO-2009143489-A2 | MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTS | ARCHER PHARMACEUTICALS, INC. (US) | 2009-11-26 | — | — | WO | claimed |
| EP-1209234-A1 | STEREOSTRUCTURE OF DECARBAMYLASE AND METHOD OF USING THE SAME | Kaneka Corporation (JP) | 2002-05-29 | — | — | EP | claimed |
| EP-0173276-A2 | Method for the determination of substrate or enzyme activity | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1986-03-05 | — | — | EP | claimed |
| JP-61285996-A | — | — | None | — | — | JP | disclosed |
| JP-61177992-A | — | — | None | — | — | JP | disclosed |
| EP-4684030-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-20250336540-A1 | METABOLITE PREDICTORS FOR LUNG CANCER | JANSSEN PHARMACEUTICA NV (BE) | 2025-10-30 | — | — | US | disclosed |
| EP-0334358-A2 | Novel D-amidase and process for producing D-alpha-alanine and/or L-alpha-alanineamide | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1989-09-27 | — | — | EP | disclosed |
| JP-S61285996-A | PRODUCTION OF L-PHENYLALANINE | DENKI KAGAKU KOGYO KK | 1986-12-16 | — | — | JP | disclosed |
| JP-S61177992-A | PRODUCTION OF D-ALPHA-AMINO ACID | MITSUI TOATSU CHEM INC | 1986-08-09 | — | — | JP | disclosed |
| EP-0173276-A2 | Method for the determination of substrate or enzyme activity | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1986-03-05 | — | — | EP | disclosed |
| US-4237227-A | ENZYMATIC HYDROLYSIS OF A HYDANTOIN | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1980-12-02 | — | — | US | disclosed |